SEP 8, 2026 · PHASE 3 TRIAL
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
ClinicalTrials.gov
This is a recruiting Phase 3 trial registration with no results posted; it describes planned enrollment and primary outcomes but contains no efficacy or safety data.
Reported
Planned enrollment1000
Primary outcome measureChange from Baseline in Incontinence Episod…
Study phasePhase 3